Table: Immuno Biological Lab - 9-MTH group results
Feb 10 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2024 Dec 31, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 680 mln 548 mln 925 mln
(+24.0 pct) (-1.2 pct) (+13.3 pct)
Operating 124 mln 10 mln 120 mln
(+1058.9 pct) (-43.0 pct) (+15.1 pct)
Recurring 129 mln 25 mln 120 mln
(+401.0 pct) (-4.3 pct)
Net 133 mln 20 mln 115 mln
(+547.7 pct) (-38.4 pct)
EPS 14.32 yen 2.21 yen 12.30 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T